Curbstone Financial Management Corp Reduces Position in Stryker Corporation (SYK)

Curbstone Financial Management Corp decreased its position in shares of Stryker Corporation (NYSE:SYK) by 8.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,905 shares of the medical technology company’s stock after selling 175 shares during the period. Curbstone Financial Management Corp’s holdings in Stryker Corporation were worth $264,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in SYK. Bollard Group LLC boosted its position in shares of Stryker Corporation by 0.4% in the first quarter. Bollard Group LLC now owns 829 shares of the medical technology company’s stock worth $109,000 after buying an additional 3 shares during the period. Baystate Wealth Management LLC boosted its position in shares of Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock worth $139,000 after buying an additional 22 shares during the period. Guardian Life Insurance Co. of America boosted its position in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after buying an additional 9 shares during the period. Assetmark Inc. boosted its position in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after buying an additional 4 shares during the period. Finally, Mosaic Family Wealth LLC boosted its position in shares of Stryker Corporation by 3.5% in the first quarter. Mosaic Family Wealth LLC now owns 1,300 shares of the medical technology company’s stock worth $171,000 after buying an additional 44 shares during the period. 73.79% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Stryker Corporation (SYK) traded down 0.66% during mid-day trading on Thursday, hitting $146.44. 197,290 shares of the stock were exchanged. The stock has a 50-day moving average price of $144.29 and a 200 day moving average price of $136.16. The firm has a market cap of $54.78 billion, a price-to-earnings ratio of 32.69 and a beta of 0.80. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $148.84.

Stryker Corporation (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. Stryker Corporation’s revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.39 EPS. On average, equities research analysts expect that Stryker Corporation will post $6.50 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a $0.425 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.70 annualized dividend and a yield of 1.15%. Stryker Corporation’s dividend payout ratio (DPR) is currently 37.95%.

COPYRIGHT VIOLATION NOTICE: “Curbstone Financial Management Corp Reduces Position in Stryker Corporation (SYK)” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://sportsperspectives.com/2017/08/17/curbstone-financial-management-corp-reduces-position-in-stryker-corporation-syk.html.

A number of brokerages recently issued reports on SYK. BidaskClub raised shares of Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday. Cowen and Company reissued a “buy” rating and set a $160.00 price target (up from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Oppenheimer Holdings, Inc. set a $148.00 price target on shares of Stryker Corporation and gave the company a “hold” rating in a research report on Friday, July 28th. Stifel Nicolaus lifted their price target on shares of Stryker Corporation from $151.00 to $158.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Finally, Citigroup Inc. lifted their price target on shares of Stryker Corporation from $114.00 to $125.00 and gave the company a “sell” rating in a research report on Friday, June 9th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $144.03.

In related news, insider David Floyd sold 7,381 shares of the business’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $144.70, for a total value of $1,068,030.70. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the sale, the insider now owns 8,983 shares in the company, valued at $1,313,853.58. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,810 shares of company stock worth $4,754,958. 7.40% of the stock is owned by insiders.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply